Short answer. Connecticut has two rates that stack: 20 percent of the increase in research spending under the RC credit, plus an RDC credit that is a flat 6 percent for companies with prior-year gross income of $100 million or less (1 to 6 percent for larger ones). A company at $70 million or less with no Connecticut corporation business tax can exchange credits for cash worth 65 percent of their value, or 90 percent for a biotechnology company.

Key facts

RC credit (incremental)20% of the increase in Connecticut QRE
RDC credit (non-incremental)Flat 6% at $100M gross income or less; 1% to 6% above
Refundable65% cash exchange (90% biotech) at $70M gross income or less
Pass-throughs (from 2026)6% credit against personal income tax
Carryforward15 years (credits earned 2021 on)
FormsCT-1120 RC and CT-1120 RDC

The two rates, and how they stack

Connecticut runs two research credits in parallel, under two statutes.

The RC credit under Conn. Gen. Stat. 12-217j is 20 percent of the increase in your qualified research expenses over the prior year. It is the incremental piece, structurally like the federal Regular credit but at a higher rate.

The RDC credit under 12-217n is non-incremental: it applies to Connecticut research spending net of the amount used for the 20 percent credit. The rate is a flat 6 percent for a company with prior-year gross income of $100 million or less; larger companies fall into tiers from 1 to 6 percent. The two coordinate so you do not double-count, because expenses used in the RC computation reduce the RDC base for the same year. Each credit works on a different slice of your spending.

Cash for a company with no tax

The rate matters more here because a smaller company can take it as cash.

A company with prior-year gross income of $70 million or less and no Connecticut corporation business tax liability can exchange its current-year R&D credits for cash worth 65 percent of the credit amount. For a biotechnology company, Public Act 25-168 raised that to 90 percent for income years beginning on or after January 1, 2025. A $1.5 million annual cap applies.

For a pre-profit Connecticut software company, the practical pattern is to compute both credits, claim them on Forms CT-1120 RC and CT-1120 RDC, and elect the cash exchange rather than carrying the credit forward.

A 6 percent credit for pass-throughs from 2026

S corporations and partnerships now have their own rate.

Public Act 26-68, section 267 (signed May 26, 2026), adds a 6 percent R&D credit against the personal income tax for S corporations and partnerships with gross income of $70 million or less, for tax years beginning on or after January 1, 2026.

The business reserves the credit in advance through a Department of Economic and Community Development voucher. The limit is $1.5 million per business and $25 million statewide, and the credit can be exchanged at 65 percent of its value, or 90 percent for biotechnology companies.

What the rate applies to

Two rules shape the base the rate sits on.

Only research conducted in Connecticut counts. The Connecticut qualified research expense definition follows federal Section 41, so the wages, contract research, and supplies that support your federal claim also support the Connecticut credit, limited to the in-state portion.

Unused credit that you do not exchange for cash carries forward. Credits earned in income years beginning on or after January 1, 2021 carry forward 15 years; older credits carry forward until used.

Get documentation built to survive an exam

R&D Binder produces the federal Section 41 binder and the Connecticut state workpaper from one engagement, both built to survive an exam.